Phase 2
๐ Investigational Drug / Biologic
NCT07325253
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
๐ MD Anderson Cancer Center โ Houston, Texas
View Study & Screener โ